Suppr超能文献

肠道微生物群,中药治疗糖尿病的潜在新靶点。

Gut Microbiota, a Potential New Target for Chinese Herbal Medicines in Treating Diabetes Mellitus.

作者信息

Zhang Boxun, Yue Rensong, Chen Yuan, Yang Maoyi, Huang Xiaoying, Shui Jiacheng, Peng Yuliang, Chin Jiawei

机构信息

Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China.

出版信息

Evid Based Complement Alternat Med. 2019 Feb 18;2019:2634898. doi: 10.1155/2019/2634898. eCollection 2019.

Abstract

The gut microbiota, as an important factor affecting host health, plays a significant role in the occurrence and development of diabetes mellitus (DM), and the mechanism may be related to excessive endotoxins, altered short-chain fatty acids (SCFAs), and disordered bile acid metabolism. Traditional Chinese medicine (TCM) has a long history of treating DM, but its mechanism is not very clear. Recent research has suggested that Chinese herbal medicine can improve glucose metabolism by remodeling the gut microbiota, which opens new avenues for further research on hypoglycemic mechanisms. This review presents the recent progress of Chinese herbs, herbal extracts, and herbal compound preparations in treating DM through regulating the gut microbiota and summarizes the main mechanisms involved, namely, anti-inflammatory and antioxidative effects, protecting the intestinal barrier and inhibiting lipotoxicity. In addition, some suggestions for improvement are also proposed.

摘要

肠道微生物群作为影响宿主健康的重要因素,在糖尿病(DM)的发生和发展中起着重要作用,其机制可能与内毒素过多、短链脂肪酸(SCFAs)改变以及胆汁酸代谢紊乱有关。中医治疗DM历史悠久,但其机制尚不完全清楚。最近的研究表明,中药可以通过重塑肠道微生物群来改善糖代谢,这为进一步研究降糖机制开辟了新途径。本文综述了中药、草药提取物和草药复方制剂通过调节肠道微生物群治疗DM的研究进展,并总结了其主要作用机制,即抗炎和抗氧化作用、保护肠道屏障和抑制脂毒性。此外,还提出了一些改进建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77fa/6398116/ec4af03d945f/ECAM2019-2634898.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验